{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:17:08Z","timestamp":1790821028025,"version":"4.1.0"},"reference-count":143,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Skin cancers require a multidisciplinary approach. The updated guidelines introduce new insights into the management of these diseases. Melanoma (MM), the third most common skin cancer, a malignant melanocytic tumor, which is classified into four major histological subtypes, continues to have the potential to be a lethal disease. The mortality\u2013incidence ratio is higher in Eastern European countries compared to Western European countries, which shows the need for better prevention and early detection in Eastern European countries. Basal cell carcinoma (BCC) and squamous cell carcinoma (cSCC) remain the top two skin cancers, and their incidence continues to grow. The gold standard in establishing the diagnosis and establishing the histopathological subtype in BCC and SCC is a skin biopsy. Sebaceous carcinoma (SeC) is an uncommon and potentially aggressive cutaneous malignancy showing sebaceous differentiation. It accounts for 0.7% of skin cancers and 3\u20136.7% of cancer-related deaths. Due to the rapid extension to the regional lymph nodes, SeC requires early treatment. The main treatment for sebaceous carcinoma is surgical treatment, including Mohs micrographic surgery, which has the advantage of complete margin evaluation and low recurrence rates. Primary cutaneous lymphomas (PCLs) are a heterogeneous group of lymphoproliferative diseases, with no evidence of extracutaneous determination at the moment of the diagnosis. PCLs have usually a very different evolution, prognosis, and treatment compared to the lymphomas that may secondarily involve the skin. The aim of our review is to summarize the important changes in the approach to treating melanoma, non-melanoma skin, cutaneous T and B cell lymphomas, and other types of skin cancers. For all skin cancers, optimal patient management requires a multidisciplinary approach including dermatology, medical oncology, and radiation oncology.<\/jats:p>","DOI":"10.3390\/ijms241311176","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T01:41:36Z","timestamp":1688694096000},"page":"11176","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Advancing Cancer Research: Current Knowledge on Cutaneous Neoplasia"],"prefix":"10.3390","volume":"24","author":[{"given":"Laura","family":"St\u0103tescu","sequence":"first","affiliation":[{"name":"Medical III Department, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Mihaela","family":"Trandafir","sequence":"additional","affiliation":[{"name":"Department of Mother and Child, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3018-8011","authenticated-orcid":false,"given":"Elena","family":"\u021aarc\u0103","sequence":"additional","affiliation":[{"name":"Department of Surgery II\u2014Pediatric Surgery, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-8594","authenticated-orcid":false,"given":"Mihaela","family":"Moscalu","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Interdisciplinarity, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Magdalena","family":"Leon Constantin","sequence":"additional","affiliation":[{"name":"Medical I Department, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-4244","authenticated-orcid":false,"given":"L\u0103cr\u0103mioara Ionela","family":"Butnariu","sequence":"additional","affiliation":[{"name":"Department of Mother and Child, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mioara Florentina","family":"Trandafirescu","sequence":"additional","affiliation":[{"name":"Department of Morphofunctional Sciences I\u2013Pathology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela Camelia","family":"T\u00eernovanu","sequence":"additional","affiliation":[{"name":"Department of Mother and Child, Faculty of Medicine, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Heredea","sequence":"additional","affiliation":[{"name":"Department of Clinical Practical Skills, \u201cVictor Babe\u015f\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei Valentin","family":"P\u0103tra\u0219cu","sequence":"additional","affiliation":[{"name":"Department of Morphofunctional Sciences I\u2013Pathology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doru","family":"Botezat","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Interdisciplinarity, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7859-840X","authenticated-orcid":false,"given":"Elena","family":"Cojocaru","sequence":"additional","affiliation":[{"name":"Department of Morphofunctional Sciences I\u2013Pathology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/annonc\/mdz411","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Michielin","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.hoc.2018.09.005","article-title":"Cutaneous Melanoma\u2014A Review in Detection, Staging, and Management","volume":"33","author":"Rebecca","year":"2019","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_3","unstructured":"National Cancer Institute (2023, May 25). Adolescents and Young Adults with Cancer, Available online: https:\/\/www.cancer.gov\/types\/aya."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bjd.12923","article-title":"Melanoma prognosis in Europe: Far from equal","volume":"171","author":"Forsea","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jdv.17531","article-title":"Overview of guideline recommendations for the management of high-risk and advanced cutaneous squamous cell carcinoma","volume":"36","author":"Dessinioti","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/jid.2013.70","article-title":"Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by post zygotic mutations in codon 61 of NRAS","volume":"133","author":"Kinsteik","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_9","unstructured":"(2023, May 23). Available online: https:\/\/www.cancer.org\/cancer\/melanoma-skin-cancer.html."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.suc.2019.09.004","article-title":"Pathology of Melanoma","volume":"100","author":"Chopra","year":"2020","journal-title":"Surg. Clin. N. Am."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_14","unstructured":"The Cancer Genome Atlas Network (2015). Genomic Classification of Cutaneous Melanoma. Cell, 161, 1681\u20131696."},{"key":"ref_15","first-page":"809","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"361","author":"Flaherty","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_16","unstructured":"Sondak, V.K. (2017). American Society of Clinical Oncology 2017 Educational Book, American Society of Clinical Oncology (ASCO)."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2018.12.015","article-title":"Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E\/K\u2013mutant advanced or metastatic melanoma","volume":"109","author":"Robert","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"v851","DOI":"10.1093\/annonc\/mdz394.064","article-title":"LBA67 Adjuvant immunotherapy with nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma patients with no evidence of disease (NED): A randomized, double-blind phase II trial (IMMUNED)","volume":"30","author":"Schadendorf","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S1470-2045(16)30122-X","article-title":"Cobimetinib combined with vemurafenib in advanced BRAF V600-mutant melanoma (coBRIM): Updated efficacy results from a randomised, double-blind, phase 3 trial","volume":"17","author":"Ascierto","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.annonc.2020.07.005","article-title":"ESMO consensus conference recommendations on the management of locoregional melanoma: Under the auspices of the ESMO Guidelines Committee","volume":"31","author":"Michielin","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2018.03.060","article-title":"Basal Cell Carcinoma: Ep-idemiology; Pathophysiology; Clinical and Histological Subtypes; and Disease Associations","volume":"80","author":"Cameron","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pellegrini, C., Maturo, M.G., Di Nardo, L., Ciciarelli, V., Garc\u00eda-Rodrigo, C.G., and Fargnoli, M.C. (2017). Understanding the Molecular Genetics of Basal Cell Carcinoma. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112485"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2340\/00015555-2282","article-title":"Basal Cell Carcinoma is as Common as the Sum of all Other Cancers: Implications for Treatment Capacity","volume":"96","author":"Holm","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2606271","DOI":"10.1155\/2017\/2606271","article-title":"Skin Cancer and Its Treatment: Novel Treatment Approaches with Emphasis on Nanotechnology","volume":"2017","author":"Orthaber","year":"2017","journal-title":"J. Nanomater."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1365-4632.2010.04474.x","article-title":"Ultraviolet Radiation and Skin Cancer","volume":"49","author":"Narayanan","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2019.06.003","article-title":"Diagnosis and treatment of basal cell carcinoma: European consensus\u2013based interdisciplinary guidelines","volume":"118","author":"Peris","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/MLG.0b013e31802e2d88","article-title":"The Skin Cancer Index: Clinical Responsiveness and Predictors of Quality of Life","volume":"117","author":"Rhee","year":"2007","journal-title":"Laryngoscope"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ejca.2013.12.013","article-title":"Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease","volume":"50","author":"McCusker","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.currproblcancer.2015.07.004","article-title":"Basal cell carcinoma: Epidemiology, clinical and histologic features, and basic science overview","volume":"39","year":"2015","journal-title":"Curr. Probl. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cncr.21143","article-title":"Basosquamous carcinoma","volume":"104","author":"Leibovitch","year":"2005","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-0560.1996.tb01288.x","article-title":"Infundibulocystic basaloid neoplasm","volume":"23","author":"Eusebio","year":"1996","journal-title":"J. Cutan. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/2229-5178.105456","article-title":"Clinical variants, stages, and management of basal cell carcinoma","volume":"4","author":"Dourmishev","year":"2013","journal-title":"Indian Dermatol. Online J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"574","DOI":"10.6004\/jnccn.2016.0065","article-title":"Basal Cell Skin Cancer, Version 1.2016: Clinical Practice Guidelines in Oncology","volume":"14","author":"Bichakjian","year":"2016","journal-title":"JNCCN J. Natl. Compr. Cancer Netw."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2010.09.040","article-title":"Perineural Infiltration of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma Without Clinical Features","volume":"82","author":"Lin","year":"2012","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3098940","DOI":"10.1155\/2018\/3098940","article-title":"Basal Cell Carcinoma Arises from Interfollicular Layer of Epidermis","volume":"2018","author":"Tan","year":"2018","journal-title":"J. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/bjd.14042","article-title":"Systematic review of optical coherence tomography usage in the diagnosis and management of basal cell carcinoma","volume":"173","author":"Cheng","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ad.2017.07.018","article-title":"Gorlin Syndrome. S\u00edndrome de Gorlin","volume":"109","year":"2018","journal-title":"Actas Dermosifiliogr. (Engl. Ed.)"},{"key":"ref_39","first-page":"883","article-title":"Clinico-imaging and morphological aspects of the benign serous ovarian epithelial tumors in children and adolescents","volume":"60","author":"Stepan","year":"2019","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ejca.2014.08.018","article-title":"Surgical excision versus Mohs\u2019 micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up","volume":"50","author":"Mosterd","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/B:CANC.0000031775.04618.30","article-title":"Aggressive basal cell carcinoma: Presentation, pathogenesis, and management","volume":"23","author":"Walling","year":"2004","journal-title":"Cancer Metastasis Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMra044151","article-title":"Basal-Cell Carcinoma","volume":"353","author":"Rubin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PAP.0000000000000157","article-title":"Cutaneous Squamous Cell Carcinoma: Review of the Eighth Edition of the American Joint Committee on Cancer Staging Guidelines, Prognostic Factors, and Histopathologic Variants","volume":"24","author":"Motaparthi","year":"2017","journal-title":"Adv. Anat. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous Squamous Cell Carcinoma: Incidence, Risk Factors, Diagnosis, and Staging","volume":"78","author":"Que","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/jdv.13609","article-title":"The European Status Quo in legal recognition and patient-care services of occupational skin cancer","volume":"30","author":"Ulrich","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1111\/jdv.15768","article-title":"Skin cancer in outdoor workers exposed to solar radiation: A largely underreported occupational disease in Italy","volume":"33","author":"Gobba","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2018.08.001","article-title":"Cutaneous Squamous Cell Carcinoma","volume":"33","author":"Waldman","year":"2019","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1684\/ejd.2018.3248","article-title":"Do cancer registries play a role in determining the incidence of non-melanoma skin cancers?","volume":"28","author":"Lima","year":"2018","journal-title":"Eur. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejca.2018.09.001","article-title":"To Accelerate Cancer Prevention in Europe: Challenges for Cancer Registries","volume":"104","author":"Zanetti","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000377698","article-title":"Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update","volume":"2","author":"Compton","year":"2015","journal-title":"Dermatopathology"},{"key":"ref_51","first-page":"1363","article-title":"A panel of biomarkers for skin squamous cell carcinoma: Various functional entities and differential responses to resveratrol","volume":"12","author":"Sun","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Tuffaha, M.S.A., Guski, H., and Kristiansen, G. (2018). Immunohistochemistry in Tumor Diagnostics, Springer.","DOI":"10.1007\/978-3-319-53577-7"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Ansary, T.M., Hossain, R., Komine, M., and Ohtsuki, M. (2022). Immunotherapy for the Treatment of Squamous Cell Carcinoma: Potential Benefits and Challenges. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158530"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Burns, C., Kubicki, S., Nguyen, Q.-B., Aboul-Fettouh, N., Wilmas, K.M., Chen, O.M., Doan, H.Q., Silapunt, S., and Migden, M.R. (2022). Advances in Cutaneous Squamous Cell Carcinoma Management. Cancers, 14.","DOI":"10.3390\/cancers14153653"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"de Vicente, J.C., del Molino, P.D.-P., Rodrigo, J.P., Allonca, E., Hermida-Prado, F., Granda-D\u00edaz, R., Santamarta, T.R., and Garc\u00eda-Pedrero, J.M. (2019). SOX2 Expression Is an Independent Predictor of Oral Cancer Progression. J. Clin. Med., 8.","DOI":"10.3390\/jcm8101744"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Gallus, R., Gheit, T., Holzinger, D., Petrillo, M., Rizzo, D., Petrone, G., Miccich\u00e8, F., Mattiucci, G.C., Arciuolo, D., and Capobianco, G. (2022). Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma. Vaccines, 10.","DOI":"10.3390\/vaccines10020204"},{"key":"ref_57","first-page":"932","article-title":"Molecular genetics of cutaneous squamous cell carcinoma: Perspective for treatment strategies","volume":"34","author":"Pellegrini","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Goldie, S.J., Chincarini, G., and Darido, C. (2019). Targeted Therapy Against the Cell of Origin in Cutaneous Squamous Cell Carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092201"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"12510","DOI":"10.1038\/ncomms12510","article-title":"Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma","volume":"7","author":"Chahal","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/1055-9965.EPI-15-1070","article-title":"A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants","volume":"25","author":"Siiskonen","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41467-020-14594-5","article-title":"Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma","volume":"11","author":"Sarin","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.0007-0963.2001.04615.x","article-title":"Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma","volume":"146","author":"Motley","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0190-9622(92)70178-I","article-title":"Surgical margins for excision of primary cutaneous squamous cell carcinoma","volume":"27","author":"Brodland","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1017\/S0022215116000554","article-title":"Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"Newlands","year":"2016","journal-title":"J. Laryngol. Otol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/COC.0000000000000088","article-title":"Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC)","volume":"39","author":"Jarkowski","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jdcr.2019.04.006","article-title":"Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation","volume":"5","author":"Guminski","year":"2019","journal-title":"JAAD Case Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/idoj.IDOJ_8_18","article-title":"Immunohistochemistry in dermatopathology and its relevance in clinical practice","volume":"9","author":"Chatterjee","year":"2018","journal-title":"Indian Dermatol. Online J."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"P\u0142achta, I., Kleibert, M., Czarnecka, A.M., Spa\u0142ek, M., Szumera-Cie\u0107kiewicz, A., and Rutkowski, P. (2021). Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105077"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Paolino, G., Donati, M., Bottoni, U., Mercuri, S.R., and Cantisani, C. (2017). Histology of Non-Melanoma Skin Cancers: An Update. Biomedicine, 5.","DOI":"10.3390\/biomedicines5040071"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/jclinpath-2015-203228","article-title":"Challenges in the diagnosis of cutaneous adnexal tumours","volume":"68","author":"Danialan","year":"2015","journal-title":"J. Clin. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Kervarrec, T., Sohier, P., Pissaloux, D., de la Fouchardiere, A., Cribier, B., Battistella, M., and Macagno, N. (2023). Genetics of adnexal tumors: An update. Ann. Dermatol. Venereol., S0151-9638(23)00032-7.","DOI":"10.1016\/j.annder.2023.03.003"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.path.2021.03.004","article-title":"Update on Molecular Genetic Alterations of Cutaneous Adnexal Neoplasms","volume":"14","author":"Hile","year":"2021","journal-title":"Surg. Pathol. Clin."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.pathol.2017.08.012","article-title":"Sebaceous lesions of the skin","volume":"49","author":"Iacobelli","year":"2017","journal-title":"Pathology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41467-018-04008-y","article-title":"Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma","volume":"9","author":"North","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/his.12767","article-title":"Malignant sweat gland tumours: An update","volume":"67","author":"Cardoso","year":"2015","journal-title":"Histopathology"},{"key":"ref_77","first-page":"606","article-title":"Cutaneous tricholemmal carcinoma: A 15-year single center experience","volume":"156","author":"Boggio","year":"2021","journal-title":"G. Ital. J. Dermatol. Venereol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13256-017-1212-8","article-title":"Retrospective study of rare cutaneous malignant adnexal tumors of the head and neck in a tertiary care cancer hospital: A case series","volume":"11","author":"Waqas","year":"2017","journal-title":"J. Med. Case Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jamcollsurg.2021.01.019","article-title":"Malignant Cutaneous Adnexal Tumors and Role of SLNB","volume":"232","author":"Storino","year":"2021","journal-title":"J. Am. Coll. Surg."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Kleibert, M., P\u0142achta, I., Czarnecka, A.M., Spa\u0142ek, M.J., Szumera-Cie\u0107kiewicz, A., and Rutkowski, P. (2022). Treatment of Malignant Adnexal Tumors of the Skin: A 12-Year Perspective. Cancers, 14.","DOI":"10.3390\/cancers14040998"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/14656566.2017.1316372","article-title":"Non-melanoma skin cancer: New and future synthetic drug treatments","volume":"18","author":"Amaral","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00262-019-02334-8","article-title":"Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas","volume":"68","author":"Duverger","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/his.14441","article-title":"Molecular pathology of skin adnexal tumours","volume":"80","author":"Plotzke","year":"2022","journal-title":"Histopathology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/DSS.0000000000000152","article-title":"Sebaceous Carcinoma: Review of the Literature","volume":"41","author":"Kyllo","year":"2015","journal-title":"Dermatol. Surg."},{"key":"ref_85","first-page":"e6858","article-title":"Extraocular Sebaceous Carcinoma Presenting as a Nodule over the Zygoma","volume":"12","author":"Kraleti","year":"2020","journal-title":"Cureus"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/bjophthalmol-2012-302443","article-title":"Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma","volume":"97","author":"Muqit","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11864-017-0490-0","article-title":"Sebaceous Carcinoma: A Review of the Scientific Literature","volume":"18","author":"Knackstedt","year":"2017","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/000313481908500301","article-title":"Muir-Torre Syndrome Presenting as a Sebaceous Carcinoma of the Nasal Ala","volume":"3","author":"Coquillard","year":"2019","journal-title":"Am. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40792-020-0799-y","article-title":"Sebaceous carcinoma of the breast predominantly characterized by intraductal growth: A case report","volume":"6","author":"Ohno","year":"2020","journal-title":"Surg. Case Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjd.13706","article-title":"Eyelid sebaceous carcinoma: A novel mutation in lymphoid enhancer-binding factor-1","volume":"173","author":"Jayaraj","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/bjo.2009.177204","article-title":"Does -catenin have a role in pathogenesis of sebaceous cell carcinoma of the eyelid?","volume":"95","author":"Jayaraj","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.09-4127","article-title":"Analysis of p53 Mutations and the Expression of p53 and p21WAF1\/CIP1Protein in 15 Cases of Sebaceous Carcinoma of the Eyelid","volume":"51","author":"Kiyosaki","year":"2010","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4103\/ijo.IJO_399_17","article-title":"Immunohistochemical expression of X-linked inhibitor of apoptosis in eyelid sebaceous gland carcinoma predicts a worse prognosis","volume":"65","author":"Jayaraj","year":"2017","journal-title":"Indian J. Ophthalmol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/IOP.0b013e31816d925f","article-title":"Sebaceous Cell Carcinoma of the Ocular Adnexa: Clinical Presentations, Histopathology, and Outcomes","volume":"24","author":"Song","year":"2008","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.det.2015.06.001","article-title":"Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma","volume":"33","author":"Olsen","year":"2015","journal-title":"Dermatol. Clin."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A Variant of Lymphomatoid Papulosis Simulating Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-cell Lymphoma. Description of 9 Cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive Lymphomatoid Papulosis: A New Variant Simulating Aggressive Lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.semdp.2016.11.005","article-title":"A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders","volume":"34","author":"Kempf","year":"2017","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_99","first-page":"1375","article-title":"Differential diagnosis difficulties related to infantile hemangioma\u2014Case report and literature review","volume":"60","author":"Cojocaru","year":"2019","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.47162\/RJME.61.3.07","article-title":"Morphological, genetic and clinical correlations in infantile hemangiomas and their mimics","volume":"61","author":"Luca","year":"2020","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK\u2013cell lymphoproliferative diseases in nonimmunocompromised hosts: Prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive Lymphoid Proliferation of the Ear","volume":"31","author":"Petrella","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/DAD.0b013e3182a74c7a","article-title":"Multicenter Case Series of Indolent Small\/Medium-Sized CD8+ Lymphoid Proliferations with Predilection for the Ear and Face","volume":"36","author":"Li","year":"2014","journal-title":"Am. J. Dermatopathol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/bjd.13628","article-title":"CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas","volume":"172","author":"Wobser","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/ajh.25224","article-title":"Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management","volume":"93","author":"Wilcox","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_106","first-page":"103","article-title":"Multiple versus unifocal breast cancer: Clinicopathological and immunohistochemical differences","volume":"60","author":"Radu","year":"2019","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CCO.0000000000000427","article-title":"Cutaneous angiosarcoma: Update on biology and latest treatment","volume":"30","author":"Ishida","year":"2018","journal-title":"Curr. Opin. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.2921","article-title":"Recurrent PTPRB and PLCG1 mutations in angiosarcoma","volume":"46","author":"Behjati","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1158\/0008-5472.CAN-15-0418","article-title":"NUP160-SLC43A3 is a novel recurrent fusion oncogene in angiosarcoma","volume":"75","author":"Shimozono","year":"2015","journal-title":"Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"36041","DOI":"10.18632\/oncotarget.5936","article-title":"Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway","volume":"6","author":"Murali","year":"2015","journal-title":"Oncotarget"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Tarc\u0103, E., Cojocaru, E., Trandafir, L.M., Luca, A.C., Melinte Popescu, A.S., Butnariu, L.I., Melinte Popescu, M.G., Anton P\u0103duraru, D.T., Moscalu, M., and Rusu, D. (2022). Ganglioneuroma of the Bladder in Association with Neurofibromatosis Type 1. Diagnostics, 12.","DOI":"10.3390\/diagnostics12123126"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1111\/cas.13379","article-title":"Survivin: A novel marker and potential therapeutic target for human angiosarcoma","volume":"108","author":"Tsuneki","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"823","DOI":"10.7150\/jca.14461","article-title":"Prognostic significance of forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in angiosarcoma","volume":"7","author":"Ito","year":"2016","journal-title":"J. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11864-021-00933-1","article-title":"Management of Cutaneous Angiosarcoma: An Update Review","volume":"23","author":"Bi","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Ramakrishnan, N., Mokhtari, R., Charville, G.W., Bui, N., and Ganjoo, K. (2022). Cutaneous Angiosarcoma of the Head and Neck\u2014A Retrospective Analysis of 47 Patients. Cancers, 14.","DOI":"10.3390\/cancers14153841"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JGO.2016.005843","article-title":"Positive PD-L1 expression predicts worse outcome in cutaneous angiosarcoma","volume":"3","author":"Shimizu","year":"2017","journal-title":"J. Glob. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1090168","DOI":"10.3389\/fmed.2023.1090168","article-title":"Cutaneous angiosarcoma: A review of current evidence for treatment with checkpoint inhibitors","volume":"10","author":"Guan","year":"2023","journal-title":"Front. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e28773","DOI":"10.1002\/jmv.28773","article-title":"Today\u2019s Kaposi sarcoma is not the same as it was 40 years ago, or is it?","volume":"95","author":"Damania","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.NAJ.0000901848.07128.92","article-title":"CE: HIV-Associated Kaposi Sarcoma in the Combination Antiretroviral Therapy Era","volume":"122","author":"Mangusan","year":"2022","journal-title":"Am. J. Nurs."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Grabar, S., and Costagliola, D. (2021). Epidemiology of Kaposi\u2019s Sarcoma. Cancers, 13.","DOI":"10.3390\/cancers13225692"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Apalla, Z., Liopyris, K., Kyrmanidou, E., Fotiadou, C., Sgouros, D., Patsatsi, A., Trakatelli, M.-G., Kalloniati, E., Lallas, A., and Lazaridou, E. (2023). Clinical and Dermoscopic Characteristics of Cutaneous Sarcomas: A Literature Review. Diagnostics, 13.","DOI":"10.3390\/diagnostics13101822"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Palich, R., Makinson, A., Veyri, M., Guihot, A., Valantin, M.-A., Br\u00e9gigeon-Ronot, S., Poizot-Martin, I., Solas, C., Grabar, S., and Martin-Blondel, G. (2021). Kaposi\u2019s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition. Cancers, 13.","DOI":"10.3390\/cancers13225702"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e2023027","DOI":"10.4084\/MJHID.2023.027","article-title":"Kaposi Sarcoma in People Living with HIV: Is it Water under the Bridge?","volume":"15","author":"Papalini","year":"2023","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1080\/09546634.2022.2083544","article-title":"Kaposi\u2019s sarcoma management from a plastic surgery perspective","volume":"33","author":"Taskin","year":"2022","journal-title":"J. Dermatolog. Treat."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Qu\u00e9ro, L., Palich, R., Valantin, M.-A., and on behalf of CANCERVIH Working Group (2022). The Role of Radiotherapy in Treating Kaposi\u2019s Sarcoma in HIV Infected Patients. Cancers, 14.","DOI":"10.3390\/cancers14081915"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e32866","DOI":"10.1097\/MD.0000000000032866","article-title":"Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study","volume":"102","author":"Paksoy","year":"2023","journal-title":"Medicine"},{"key":"ref_127","first-page":"746","article-title":"Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data","volume":"21","author":"Cubukcu","year":"2021","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Naimo, E., Zischke, J., and Schulz, T.F. (2021). Recent Advances in Developing Treatments of Kaposi\u2019s Sarcoma Herpesvirus-Related Diseases. Viruses, 13.","DOI":"10.3390\/v13091797"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e28396","DOI":"10.1002\/jmv.28396","article-title":"Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma","volume":"95","author":"Gu","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Valantin, M.-A., Royston, L., Hentzien, M., Jary, A., Makinson, A., Veyri, M., Ronot-Bregigeon, S., Isnard, S., Palich, R., and Routy, J.-P. (2022). Therapeutic Perspectives in the Systemic Treatment of Kaposi\u2019s Sarcoma. Cancers, 14.","DOI":"10.3390\/cancers14030484"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Hao, X., Billings, S.D., Wu, F., Stultz, T.W., Procop, G.W., Mirkin, G., and Vidimos, A.T. (2020). Dermatofibrosarcoma Protuberans: Update on the Diagnosis and Treatment. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061752"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"\u0162arc\u0103, E., Cojocaru, E., Luca, A.C., Trandafir, L.M., Ro\u015fu, S.T., Munteanu, V., \u021aarc\u0103, V., Budacu, C.C., and Costea, C.F. (2022). Unusual Case of Masseter Muscle Hypertrophy in Adolescence\u2014Case Report and Literature Overview. Diagnostics, 12.","DOI":"10.3390\/diagnostics12020505"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Beaziz, J., Battistella, M., Delyon, J., Farges, C., Marco, O., Pages, C., Le Maignan, C., Da Meda, L., Basset-Seguin, N., and Resche-Rigon, M. (2021). Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans. Cancers, 13.","DOI":"10.3390\/cancers13092224"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/ced\/llac111","article-title":"Review of dermatofibrosarcoma protuberans","volume":"48","author":"Lim","year":"2023","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/DSS.0000000000003771","article-title":"COL1A1-PDGFB Fusion Gene Detection Through Bulk RNA-Seq and Transcriptomic Features of Dermatofibrosarcoma Protuberans","volume":"49","author":"Peng","year":"2023","journal-title":"Dermatol Surg."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.abd.2020.10.003","article-title":"Cutaneous leiomyosarcoma: A 20-year retrospective study and review of the literature","volume":"96","author":"Filipe","year":"2021","journal-title":"An. Bras. de Dermatol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/DSS.0000000000002029","article-title":"Cutaneous Leiomyosarcoma: A SEER Database Analysis","volume":"46","author":"Sandhu","year":"2020","journal-title":"Dermatol. Surg."},{"key":"ref_138","first-page":"e10","article-title":"Primary cutaneous leiomyosar-coma: A single institution study treated with modified Mohs surgery","volume":"62","author":"Llombart","year":"2023","journal-title":"Int. J. Dermatol."},{"key":"ref_139","first-page":"555","article-title":"S1-guideline cutaneous and subcutaneous leiomyosarcoma","volume":"21","author":"Helbig","year":"2023","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncr.22395","article-title":"Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group","volume":"109","author":"Svarvar","year":"2007","journal-title":"Cancer"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Zwijnenburg, E.M., Lubeek, S.F., Werner, J.E., Amir, A.L., Weijs, W.L., Takes, R.P., Pegge, S.A., van Herpen, C.M., Adema, G.J., and Kaanders, J.H.A.M. (2021). Merkel Cell Carcinoma: New Trends. Cancers, 13.","DOI":"10.3390\/cancers13071614"},{"key":"ref_142","unstructured":"(2023, May 26). Available online: www.nccn.org\/professionals\/physician_gls\/pdf\/mcc.pdf."},{"key":"ref_143","first-page":"305","article-title":"S2k Guideline\u2014Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin)\u2014Update 2022","volume":"21","author":"Becker","year":"2023","journal-title":"J. Dtsch. Dermatol. Gesellschaft."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/11176\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:07:35Z","timestamp":1760126855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/11176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":143,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ijms241311176"],"URL":"https:\/\/doi.org\/10.3390\/ijms241311176","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]}}}